These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 7858424

  • 1. Introduction of additional charges as an aid in protein purification: isolation of elongation factor 2 from Sulfolobus acidocaldarius by preparative isoelectric focusing before and after ADP-ribosylation.
    Siegmund KD, Klink F.
    Protein Expr Purif; 1994 Dec; 5(6):553-8. PubMed ID: 7858424
    [Abstract] [Full Text] [Related]

  • 2. Properties of the purified elongation factor 2 in the thermoacidophilic archaebacterium Sulfolobus solfataricus.
    Raimo G, Masullo M, Dello Russo A, Parente A, Gambacorta A, Bocchini V.
    Ital J Biochem; 1993 Dec; 42(1):1-11. PubMed ID: 8468156
    [Abstract] [Full Text] [Related]

  • 3. Expression of non-ADP-ribosylatable, diphtheria toxin-resistant elongation factor 2 in Saccharomyces cerevisiae.
    Kimata Y, Harashima S, Kohno K.
    Biochem Biophys Res Commun; 1993 Mar 31; 191(3):1145-51. PubMed ID: 8466491
    [Abstract] [Full Text] [Related]

  • 4. Endogenous ADP-ribosylation for eukaryotic elongation factor 2: evidence of two different sites and reactions.
    Bektaş M, Nurten R, Ergen K, Bermek E.
    Cell Biochem Funct; 2006 Mar 31; 24(4):369-80. PubMed ID: 16142694
    [Abstract] [Full Text] [Related]

  • 5. Characterization of the endogenous ADP-ribosylation of wild-type and mutant elongation factor 2 in eukaryotic cells.
    Fendrick JL, Iglewski WJ, Moehring JM, Moehring TJ.
    Eur J Biochem; 1992 Apr 01; 205(1):25-31. PubMed ID: 1313365
    [Abstract] [Full Text] [Related]

  • 6. Crystal structure of diphtheria toxin bound to nicotinamide adenine dinucleotide.
    Bell CE, Eisenberg D.
    Biochemistry; 1996 Jan 30; 35(4):1137-49. PubMed ID: 8573568
    [Abstract] [Full Text] [Related]

  • 7. Production of an antiserum specific to the ADP-ribosylated form of elongation factor 2 from archaebacteria and eukaryotes.
    Siegmund KD, Klink F.
    FEBS Lett; 1992 Nov 09; 312(2-3):139-42. PubMed ID: 1426243
    [Abstract] [Full Text] [Related]

  • 8. Transition state structure for ADP-ribosylation of eukaryotic elongation factor 2 catalyzed by diphtheria toxin.
    Parikh SL, Schramm VL.
    Biochemistry; 2004 Feb 10; 43(5):1204-12. PubMed ID: 14756556
    [Abstract] [Full Text] [Related]

  • 9. 1-N6-Etheno-ADP-ribosylation of elongation factor-2 by diphtheria toxin.
    Giovane A, Balestrieri C, Quagliuolo L, Servillo L.
    FEBS Lett; 1985 Oct 28; 191(2):191-4. PubMed ID: 2996930
    [Abstract] [Full Text] [Related]

  • 10. Heterogeneity of native rat liver elongation factor 2.
    Marzouki A, Lavergne JP, Reboud JP, Reboud AM.
    FEBS Lett; 1989 Sep 11; 255(1):72-6. PubMed ID: 2792373
    [Abstract] [Full Text] [Related]

  • 11. Purification of a nitric oxide-stimulated ADP-ribosylated protein using biotinylated beta-nicotinamide adenine dinucleotide.
    Zhang J, Snyder SH.
    Biochemistry; 1993 Mar 09; 32(9):2228-33. PubMed ID: 8443164
    [Abstract] [Full Text] [Related]

  • 12. Structure-activity relationships in diphtheria toxin and exotoxin A from Pseudomonas aeruginosa.
    Collier RJ, Gilliland DG, Lory S.
    Prog Clin Biol Res; 1979 Mar 09; 31():751-9. PubMed ID: 119972
    [Abstract] [Full Text] [Related]

  • 13. Purification and properties of an altered form of elongation factor 2 from mutant cells resistant to intoxication by diphtheria toxin.
    Iglewski WJ, Lee H.
    Eur J Biochem; 1983 Aug 01; 134(2):237-40. PubMed ID: 6307688
    [Abstract] [Full Text] [Related]

  • 14. Effect of oxidative stress on in vivo ADP-ribosylation of eukaryotic elongation factor 2.
    Bektaş M, Akçakaya H, Aroymak A, Nurten R, Bermek E.
    Int J Biochem Cell Biol; 2005 Jan 01; 37(1):91-9. PubMed ID: 15381153
    [Abstract] [Full Text] [Related]

  • 15. Purification of elongation factor 2 from human placenta and evidence of its fragmentation patterns in various eukaryotic sources.
    Giovane A, Servillo L, Quagliuolo L, Balestrieri C.
    Biochem J; 1987 Jun 01; 244(2):337-44. PubMed ID: 3663126
    [Abstract] [Full Text] [Related]

  • 16. Reduced ribosomal binding of eukaryotic elongation factor 2 following ADP-ribosylation. Difference in binding selectivity between polyribosomes and reconstituted monoribosomes.
    Nygård O, Nilsson L.
    Biochim Biophys Acta; 1985 Feb 20; 824(2):152-62. PubMed ID: 3970930
    [Abstract] [Full Text] [Related]

  • 17. Endogenous ADP-ribosylation of eukaryotic elongation factor 2 and its 32 kDa tryptic fragment.
    Ergen K, Bektaş M, Gökçe S, Nurten R.
    Biocell; 2007 Feb 20; 31(1):61-6. PubMed ID: 17665640
    [Abstract] [Full Text] [Related]

  • 18. Heterogeneity of cardiac rat and human elongation factor 2.
    Jäger D, Seliger C, Redpath NT, Friedrich I, Silber RE, Pönicke K, Werdan K, Müller-Werdan U.
    Electrophoresis; 2000 Jul 20; 21(13):2729-36. PubMed ID: 10949152
    [Abstract] [Full Text] [Related]

  • 19. Isolation and properties of the trypsin-derived ADP-ribosyl peptide from diphtheria toxin-modified yeast elongation factor 2.
    Van Ness BG, Howard JB, Bodley JW.
    J Biol Chem; 1978 Dec 25; 253(24):8687-90. PubMed ID: 721806
    [Abstract] [Full Text] [Related]

  • 20. Nucleotide binding to elongation factor 2 inactivated by diphtheria toxin.
    Burns G, Abraham AK, Vedeler A.
    FEBS Lett; 1986 Nov 24; 208(2):217-20. PubMed ID: 3780964
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.